Hansa Biopharma enters into agreement with AskBio to evaluate feasibility of imlifidase as ...

Retrieved on: 2022-01-05 08:55:58

Tags for this article:

Branches of biology

Life Sciences

Inborn errors of carbohydrate metabolism

Glycogen storage disease type II

Acid alpha-glucosidase

Adeno-associated virus

Gene therapy

Maltase

Hansa Biopharma AB

Click the tags to see associated articles and topics

Hansa Biopharma enters into agreement with AskBio to evaluate feasibility of imlifidase as .... View article details on hiswai:

Excerpt

Hansa Biopharma AB, “Hansa”, (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced that it has ...

Article found on: www.pharmiweb.com

View Original Article